about
Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes researchPathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?MRI guidance for accelerated partial breast irradiation in prone position: imaging protocol design and evaluation.Nonisocentric treatment strategy for breast radiation therapy: a proof of concept study.Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.Breast magnetic resonance imaging alters patient selection for accelerated partial breast irradiation.Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation.Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.Predictors of local recurrence after breast-conservation therapy.Phyllodes tumors of the breast: natural history, diagnosis, and treatment.Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.ACR Appropriateness Criteria® conservative surgery and radiation--stage I and II breast carcinoma: expert panel on radiation oncology: breast.ACR appropriateness criteria® locally advanced breast cancer.ACR appropriateness criteria(®) ductal carcinoma in situ.ACR Appropriateness Criteria® local-regional recurrence (LR) and salvage surgery: breast cancer.ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer.Solid malignancies in individuals with Down syndrome: a case presentation and literature review.Trajectory Modulated Arc Therapy: A Fully Dynamic Delivery With Synchronized Couch and Gantry Motion Significantly Improves Dosimetric Indices Correlated With Poor Cosmesis in Accelerated Partial Breast Irradiation.ACR Appropriateness Criteria® Ductal Carcinoma in Situ.Trajectory modulated prone breast irradiation: a LINAC-based technique combining intensity modulated delivery and motion of the couch.Evolving trends in the initial locoregional management of male breast cancer.Impact of a Sit-Stand Workstation on Chronic Low Back Pain: Results of a Randomized Trial.Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions.CT-Guided Wire Localization for Involved Axillary Lymph Nodes After Neo-adjuvant Chemotherapy in Patients With Initially Node-Positive Breast Cancer.Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast.Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
P50
Q28267134-E1FF9CAE-062A-4CF5-945A-E42AFD63C275Q30671803-085AA05A-E972-43AA-9A4E-2144B37AD17DQ33223403-621787F9-0C52-47CE-A49F-1DA96BCFD12FQ33486933-D7D0C07B-A46F-4760-A67F-2667AF3BDFE8Q33567567-3793FEA0-872D-4FC6-B6A0-BF8A9F6C77F0Q33838653-9CDC9AAE-8040-46D4-9397-E621397A3838Q34527592-6CC5BDBF-64DC-44A3-9E50-D4E5B4B74C3BQ34677231-E56867E9-38E9-4E6F-BE3C-AF3D2AC21263Q36056964-98AB866D-4F9C-41A5-BA3A-700E0EA7EA9EQ36062211-9CB376A9-36A7-414A-A8B9-36468A5EA1C6Q36794031-C53A2654-874A-4759-95D5-C797925E404DQ37639243-89D6AC6C-B173-4DF5-B11A-FEC1F1395C76Q37905913-A98366E9-F0C8-480C-AA27-191AEAF3D20BQ37929856-22233CAC-EB21-43C9-9BB9-A10DB6880A7EQ37959573-AA3ABF77-24FC-4623-A7D7-B1120628B1F7Q37995473-18FEBA26-B226-4163-B15E-872777564DA8Q38202127-07E3AB8F-520C-4335-A123-E60089141A02Q38264188-EE9DCA62-77BC-482C-A07B-F1DCD4BE5AFEQ38413451-8793A2F1-B993-44E9-A65C-F85CADA96C04Q38531784-810FE7BE-45D1-4707-A7B4-217164777332Q44863688-3F530359-548D-4780-A6A4-0EA7E249F256Q45909705-67A3C1AF-E066-4842-9755-086ECB724475Q46122266-CD13581E-E5D6-4B49-94D4-5301F09278F6Q46383705-1F10EA6D-52B3-4F43-B130-6C8D208488B8Q46691475-E5814EAA-D782-41FC-AAE8-B22E03EBF2EEQ50000583-2CE5680F-BA8F-497D-A31A-205949808261Q52653432-7220C675-2CD7-405C-A4DE-D2AD4ACB501F
P50
name
Kathleen C Horst
@ast
Kathleen C Horst
@en
Kathleen C Horst
@nl
type
label
Kathleen C Horst
@ast
Kathleen C Horst
@en
Kathleen C Horst
@nl
prefLabel
Kathleen C Horst
@ast
Kathleen C Horst
@en
Kathleen C Horst
@nl